Gadoteridol
C17H29GdN4O7
558.68
Gadolinium, [10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-N 1 ,N 4 ,N 7 ,N 10 ,O 1 ,O 4 ,O 7 ,O 10 ]-.
(±)-[10-(2-Hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)]gadolinium [120066-54-8]
Gadolinium, [10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)-N 1 ,N 4 ,N 7 ,N 10 ,O 1 ,O 4 ,O 7 ,O 10 ]-.
(±)-[10-(2-Hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetato(3-)]gadolinium [120066-54-8]
» Gadoteridol contains not less than 97.0 percent and not more than 101.0 percent of C17H29GdN4O7, calculated on the anhydrous basis.
USP REFERENCE STANDARDS FOR PURCHASE
USP Gadoteridol RSUSP Gadoteridol Related Compound A RS
USP Gadoteridol Related Compound B RS
USP Gadoteridol Related Compound C RS